Sino Biopharmaceutical is acquiring the remaining stake in LaNova Medicines for US $950.9 million to bolster its cancer drug ...

Led Network Rooted in Clinical Excellence and Shared Value CHICAGO, IL / ACCESS Newswire / July 16, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists ...